These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 14732923

  • 1. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
    Side LE, Curtiss NP, Teel K, Kratz C, Wang PW, Larson RA, Le Beau MM, Shannon KM.
    Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
    [Abstract] [Full Text] [Related]

  • 2. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
    Fidler C, Watkins F, Bowen DT, Littlewood TJ, Wainscoat JS, Boultwood J.
    Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941
    [Abstract] [Full Text] [Related]

  • 3. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome.
    Au WY, Fung AT, Ma ES, Liang RH, Kwong YL.
    Cancer Genet Cytogenet; 2004 Mar; 149(2):169-72. PubMed ID: 15036894
    [Abstract] [Full Text] [Related]

  • 4. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH, Andersen MK, Desta F, Pedersen-Bjergaard J.
    Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
    [Abstract] [Full Text] [Related]

  • 5. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
    Xu F, Taki T, Yang HW, Hanada R, Hongo T, Ohnishi H, Kobayashi M, Bessho F, Yanagisawa M, Hayashi Y.
    Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
    [Abstract] [Full Text] [Related]

  • 6. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA, Le Beau MM.
    Chem Biol Interact; 2005 May 30; 153-154():187-95. PubMed ID: 15935816
    [Abstract] [Full Text] [Related]

  • 7. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY, Huang CF, Wang PN, Wu JH, Lin TL, Dunn P, Kuo MC.
    Leukemia; 2004 Mar 30; 18(3):466-75. PubMed ID: 14737077
    [Abstract] [Full Text] [Related]

  • 8. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
    Shih LY, Lin TL, Wang PN, Wu JH, Dunn P, Kuo MC, Huang CF.
    Cancer; 2004 Sep 01; 101(5):989-98. PubMed ID: 15329908
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
    Andersson A, Johansson B, Lassen C, Mitelman F, Billström R, Fioretos T.
    Eur J Haematol; 2004 May 01; 72(5):307-13. PubMed ID: 15059064
    [Abstract] [Full Text] [Related]

  • 10. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
    Chen W, Jones D, Medeiros LJ, Luthra R, Lin P.
    Br J Haematol; 2005 Sep 01; 130(5):726-8. PubMed ID: 16115128
    [Abstract] [Full Text] [Related]

  • 11. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.
    Moreno I, Martín G, Bolufer P, Barragán E, Rueda E, Román J, Fernández P, León P, Mena A, Cervera J, Torres A, Sanz MA.
    Haematologica; 2003 Jan 01; 88(1):19-24. PubMed ID: 12551822
    [Abstract] [Full Text] [Related]

  • 12. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.
    Clin Cancer Res; 2005 Feb 15; 11(4):1416-24. PubMed ID: 15746041
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y, Kiyoi H, Tsujimura A, Miyawaki S, Miyazaki Y, Kuriyama K, Tomonaga M, Naoe T.
    Eur J Haematol; 2009 Aug 15; 83(2):90-8. PubMed ID: 19309322
    [Abstract] [Full Text] [Related]

  • 14. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N, Albin M, Rylander L, Billström R, Ahlgren T, Mikoczy Z, Björk J, Strömberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B.
    Leukemia; 2002 Dec 15; 16(12):2366-78. PubMed ID: 12454741
    [Abstract] [Full Text] [Related]

  • 15. FLT3 mutations in myeloid sarcoma.
    Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, Cooper L, Long P, Allan RH, Borowitz MJ, Berg KD, Murphy KM.
    Br J Haematol; 2004 Sep 15; 126(6):785-91. PubMed ID: 15352981
    [Abstract] [Full Text] [Related]

  • 16. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
    Muñoz L, Aventín A, Villamor N, Juncà J, Acebedo G, Domingo A, Rozman M, Torres JP, Tormo M, Nomdedéu JF.
    Haematologica; 2003 Jun 15; 88(6):637-45. PubMed ID: 12801839
    [Abstract] [Full Text] [Related]

  • 17. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
    Auewarakul CU, Lauhakirti D, Tocharoentanaphol C.
    Eur J Haematol; 2006 Jul 15; 77(1):51-6. PubMed ID: 16573741
    [Abstract] [Full Text] [Related]

  • 18. Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia.
    Gratias EJ, Liu YL, Meleth S, Castleberry RP, Emanuel PD.
    Pediatr Blood Cancer; 2005 Feb 15; 44(2):142-6. PubMed ID: 15390271
    [Abstract] [Full Text] [Related]

  • 19. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M, Hélias C, Struski S, Perrusson N, Uettwiller F, Mozziconacci MJ, Lafage-Pochitaloff M, Dastugue N, Terré C, Brizard F, Cornillet-Lefebvre P, Mugneret F, Barin C, Herry A, Luquet I, Desangles F, Michaux L, Verellen-Dumoulin C, Perrot C, Van den Akker J, Lespinasse J, Eclache V, Berger R, Groupe Francophone de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 2007 Jul 01; 176(1):1-21. PubMed ID: 17574959
    [Abstract] [Full Text] [Related]

  • 20. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S.
    Haematologica; 2005 Dec 01; 90(12):1617-25. PubMed ID: 16330434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.